Migraine headaches.
D002110:Caffeine / Q000008:administration & dosage; D003276:Contraceptives, Oral; D003533:Cyproheptadine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008784:Methysergide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010551:Personality; D011433:Propranolol / Q000627:therapeutic use; D012008:Recurrence; D013312:Stress, Physiological / Q000150:complications; D013375:Substance Withdrawal Syndrome; D014149:Tranquilizing Agents / Q000627:therapeutic use
D003276:Contraceptives, Oral; D004232:Diuretics; D004338:Drug Combinations; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D003533:Cyproheptadine; D002110:Caffeine; D011433:Propranolol; D004878:Ergotamine; D008784:Methysergide